Does RITUXIMAB Cause Reversible cerebral vasoconstriction syndrome? 24 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 24 reports of Reversible cerebral vasoconstriction syndrome have been filed in association with RITUXIMAB (Rituxan). This represents 0.0% of all adverse event reports for RITUXIMAB.
24
Reports of Reversible cerebral vasoconstriction syndrome with RITUXIMAB
0.0%
of all RITUXIMAB reports
1
Deaths
7
Hospitalizations
How Dangerous Is Reversible cerebral vasoconstriction syndrome From RITUXIMAB?
Of the 24 reports, 1 (4.2%) resulted in death, 7 (29.2%) required hospitalization.
Is Reversible cerebral vasoconstriction syndrome Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RITUXIMAB. However, 24 reports have been filed with the FAERS database.
What Other Side Effects Does RITUXIMAB Cause?
Off label use (39,751)
Drug ineffective (32,186)
Rheumatoid arthritis (19,850)
Pain (16,675)
Fatigue (15,602)
Arthralgia (12,529)
Rash (12,102)
Drug intolerance (11,876)
Infusion related reaction (11,871)
Joint swelling (11,170)
What Other Drugs Cause Reversible cerebral vasoconstriction syndrome?
ESCITALOPRAM OXALATE (165)
FLUOXETINE (154)
TACROLIMUS (127)
METHYLPREDNISOLONE (119)
SUMATRIPTAN (105)
VENLAFAXINE (105)
DULOXETINE (102)
SERTRALINE (102)
MYCOPHENOLATE MOFETIL (68)
CITALOPRAM HYDROBROMIDE (64)
Which RITUXIMAB Alternatives Have Lower Reversible cerebral vasoconstriction syndrome Risk?
RITUXIMAB vs RITUXIMAB-ABBS
RITUXIMAB vs RITUXIMAB-ARRX
RITUXIMAB vs RITUXIMAB-PVVR
RITUXIMAB vs RIVAROXABAN
RITUXIMAB vs RIVASTIGMINE